Medtronic HeartWare Ventricular Assist Device (HVAD) System/licence (2021-08-11)
Medtronic HeartWare Ventricular Assist Device (HVAD) System/licence (2021-08-11)
https://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2021/76321r-eng.php
Medtronic HeartWare Ventricular Assist Device (HVAD) System/licence (2021-08-11)
https://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2021/76321r-eng.php
Sistema de aquecimento corporal para cirurgias cardíacas e sala de procedimentos do Instituto Nacional de Cardiologia – RJ
https://sites.bvsalud.org/redetsa/brisa/resource/?id=biblioref.referencesource.1284262
FDA Denies Marketing Applications for About 55,000 Flavored E-Cigarette Products for Failing to Provide Evidence They Appropriately Protect Public Health
http://www.fda.gov/news-events/press-announcements/fda-denies-marketing-applications-about-55000-flavored-e-cigarette-products-failing-provide-evidence
FDA Releases PFAS Testing Results from First Survey of Nationally Distributed Processed Foods
http://www.fda.gov/news-events/press-announcements/fda-releases-pfas-testing-results-first-survey-nationally-distributed-processed-foods
Vacunados contra COVID-19 mayores de 30 años se les adelantará segunda dosis a partir de las 8 semanas de haber recibido la primera
25 de agosto del 2021. La Comisión Nacional de Vacunación y Epidemiología acordó adelantar la aplicación de la segunda dosis de la vacuna contra Covid-19...
Potential contamination of health products manufactured by Eco-Med Pharmaceuticals Inc. may pose health risks to Canadians
https://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2021/76307a-eng.php
Plasma de convalecientes para el tratamiento de pacientes con COVID-19
https://sites.bvsalud.org/redetsa/brisa/resource/?id=biblioref.referencesource.1281404
Bloqueantes de receptores de angiotensina-II de novo para el tratamiento de pacientes con COVID-19
https://sites.bvsalud.org/redetsa/brisa/resource/?id=biblioref.referencesource.1281399